Zobrazeno 1 - 1
of 1
pro vyhledávání: ''
Publikováno v:
Pain Management. 6:427-434
175 Background: Sublingual fentanyl spray is indicated for the treatment of breakthrough cancer pain (BTCP) in opioid-tolerant patients receiving around-the-clock (ATC) opioids. This post hoc analysis characterized patients receiving ATC transdermal